VDAC1 and glioblastoma: In our previous studies, the effect of VDAC1 depletion in glioblastoma (GBM), lung, and triple negative breast cancer on tumor oncogenic properties was analyzed in the context of reprogramming metabolism, invasion, proliferation, stemness, differentiation, and angiogenesis modulation, but not on TME components [48,49].